BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8958302)

  • 41. Hierarchical clustering of flow cytometry data for the study of conventional central chondrosarcoma.
    Diaz-Romero J; Romeo S; Bovée JV; Hogendoorn PC; Heini PF; Mainil-Varlet P
    J Cell Physiol; 2010 Nov; 225(2):601-11. PubMed ID: 20506378
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Screening for potential targets for therapy in mesenchymal, clear cell, and dedifferentiated chondrosarcoma reveals Bcl-2 family members and TGFβ as potential targets.
    van Oosterwijk JG; Meijer D; van Ruler MA; van den Akker BE; Oosting J; Krenács T; Picci P; Flanagan AM; Liegl-Atzwanger B; Leithner A; Athanasou N; Daugaard S; Hogendoorn PC; Bovée JV
    Am J Pathol; 2013 Apr; 182(4):1347-56. PubMed ID: 23415961
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Minor cartilage collagens type IX and XI are expressed during embryonic stem cell-derived in vitro chondrogenesis.
    Krug D; Klinger M; Haller R; Hargus G; Büning J; Rohwedel J; Kramer J
    Ann Anat; 2013 Jan; 195(1):88-97. PubMed ID: 22959840
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mesenchymal chondrosarcoma. An immunohistochemical study.
    Swanson PE; Lillemoe TJ; Manivel JC; Wick MR
    Arch Pathol Lab Med; 1990 Sep; 114(9):943-8. PubMed ID: 2202275
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Establishment of a clonal human chondrosarcoma cell line with cartilage phenotypes.
    Takigawa M; Tajima K; Pan HO; Enomoto M; Kinoshita A; Suzuki F; Takano Y; Mori Y
    Cancer Res; 1989 Jul; 49(14):3996-4002. PubMed ID: 2736538
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clear cell chondrosarcoma.
    Kumar R; David R; Cierney G
    Radiology; 1985 Jan; 154(1):45-8. PubMed ID: 3964950
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clear cell chondrosarcoma of the head and neck.
    Mokhtari S; Mirafsharieh A
    Head Neck Oncol; 2012 Apr; 4():13. PubMed ID: 22520362
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunofluorescence localization of fibronectin in chondrosarcoma cartilage matrix.
    Kimata K; Foidart JM; Pennypacker JP; Kleinman HK; Martin GR; Hewitt AT
    Cancer Res; 1982 Jun; 42(6):2384-91. PubMed ID: 7042084
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Different effects of bone morphogenetic proteins 2, 4, 12, and 13 on the expression of cartilage and bone markers in the MC615 chondrocyte cell line.
    Valcourt U; Ronzière MC; Winkler P; Rosen V; Herbage D; Mallein-Gerin F
    Exp Cell Res; 1999 Sep; 251(2):264-74. PubMed ID: 10471312
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Resveratrol attenuates matrix metalloproteinase-9 and -2-regulated differentiation of HTB94 chondrosarcoma cells through the p38 kinase and JNK pathways.
    Gweon EJ; Kim SJ
    Oncol Rep; 2014 Jul; 32(1):71-8. PubMed ID: 24841706
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clear-celled chondrosarcoma or chondroblastic sarcoma. A new type of chondrosarcoma (author's transl)].
    Postel M; Forest M; Tomeno B; Le Charpentier Y; Roux JP; Mazabraud A; Dahdouh B; Abelanet R
    Rev Chir Orthop Reparatrice Appar Mot; 1978 Jun; 64(4):333-45. PubMed ID: 151896
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A chondrogenic gene expression signature in mesenchymal stem cells is a classifier of conventional central chondrosarcoma.
    Boeuf S; Kunz P; Hennig T; Lehner B; Hogendoorn P; Bovée J; Richter W
    J Pathol; 2008 Oct; 216(2):158-66. PubMed ID: 18702172
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ERG expression in chondrogenic bone and soft tissue tumours.
    Shon W; Folpe AL; Fritchie KJ
    J Clin Pathol; 2015 Feb; 68(2):125-9. PubMed ID: 25378537
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PTHrP and Bcl-2: essential regulatory molecules in chondrocyte differentiation and chondrogenic tumors.
    Amling M; Pösl M; Hentz MW; Priemel M; Delling G
    Verh Dtsch Ges Pathol; 1998; 82():160-9. PubMed ID: 10095428
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Parathyroid hormone enhances early and suppresses late stages of osteogenic and chondrogenic development in a BMP-dependent mesenchymal differentiation system (C3H10T1/2).
    Hollnagel A; Ahrens M; Gross G
    J Bone Miner Res; 1997 Dec; 12(12):1993-2004. PubMed ID: 9421232
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chondrocytic differentiation of peripheral neuroectodermal tumor cell line in nude mouse xenograft.
    Goji J; Sano K; Nakamura H; Ito H
    Cancer Res; 1992 Aug; 52(15):4214-20. PubMed ID: 1379122
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Localization of types I, II, and X collagen in the transplanted tumor derived from human osteogenic sarcoma.
    Haraki T; Oshima O; Kakuta S; Kimura Y; Nagumo M
    Bone; 1992; 13(2):121-8. PubMed ID: 1576007
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of collagen species in a cartilaginous tumor derived from a human osteogenic sarcoma.
    Oshima O; Haraki T; Kakuta S; Kimura Y; Nagumo M
    Calcif Tissue Int; 1994 Jun; 54(6):516-20. PubMed ID: 8082058
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of MMPs is dependent on the activity of mitogen-activated protein kinase in chondrosarcoma.
    Yao M; Wang X; Zhao Y; Wang X; Gao F
    Mol Med Rep; 2017 Feb; 15(2):915-921. PubMed ID: 28035378
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Overexpression of p53 and absent genetic mutation in clear cell chondrosarcoma.
    Park YK; Park HR; Chi SG; Ushigome S; Unni KK
    Int J Oncol; 2001 Aug; 19(2):353-7. PubMed ID: 11445851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.